Behcet's disease: from east to west

被引:206
|
作者
Davatchi, Fereydoun [1 ]
Shahram, Farhad [1 ]
Chams-Davatchi, Cheyda [1 ]
Shams, Hormoz [1 ]
Nadji, Abdolhadi [1 ]
Akhlaghi, Massoomeh [1 ]
Faezi, Tahereh [1 ]
Ghodsi, Zahra [1 ]
Faridar, Alireza [1 ]
Ashofteh, Farima [1 ]
Abdollahi, Bahar Sadeghi [1 ]
机构
[1] Univ Tehran Med Sci, Shariati Hosp, Rheumatol Res Ctr, Behcets Dis Unit, Tehran 14114, Iran
关键词
Behcet's disease; ASSOCIATION; POPULATION; INVOLVEMENT; GENE;
D O I
10.1007/s10067-010-1430-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's disease (BD) is classified among vasculitides. There are actually five nationwide surveys of BD: Iran, Japan, China, Korea, and Germany. Among case series, four are on more than 200 cases (Turkey, Morocco, Tunisia, and UK). BD was classically seen around the Silk Route. Now, it is seen everywhere. The male to female ratios were, respectively (in nationwide surveys), 1.19, 0.98, 1.34, 0.63, and 1.40 to 1. The mean age at onset was 26.2, 35.7, 33.8, 29, and 26 years. Major manifestations were seen, respectively, in nationwide surveys: mucous membrane (oral aphthosis in 97%, 98%, 98%, 99%, and 98%; genital aphthosis in 65%, 73%, 76%, 83%, and 64%); skin manifestations (pseudo-folliculitis in 57%, N/A, 31%, N/A, and 62%; erythema nodosum in 22%, N/A, 38%, N/A, and 42%; ocular manifestations in 55%, 69%, 35%, 51%, and 53%). Minor manifestations were seen, respectively, in nationwide surveys: joint manifestations in 33%, 57%, 30%, 38%, and 53%; neurological manifestations in 9%, 11%, 6.5%, 4.6%, and 11%; gastrointestinal manifestations in 7%, 15.5%, 9%, 7.3%, and 12%; vascular involvement in 8.9%, 8.9%, 7.7%, 1.8%, and 13%; pulmonary manifestations in 0.3%, N/A, 2.2%, N/A, and 3.6%; cardiac manifestations in 0.5%, N/A, 4%, N/A, and 3.2%. Laboratory tests are not useful except the pathergy test, which was positive in 54%, 44%, N/A, 40%, and 34% of cases. ESR was normal in many patients. Diagnosis is based upon clinical manifestations. The International Criteria for Behcet's Disease (ICBD, 2006) may be of help, having a sensitivity of 98.2% and a specificity of 95.6% in Iranian patients.
引用
收藏
页码:823 / 833
页数:11
相关论文
共 50 条
  • [1] Behcet’s disease: from east to west
    Fereydoun Davatchi
    Farhad Shahram
    Cheyda Chams-Davatchi
    Hormoz Shams
    Abdolhadi Nadji
    Massoomeh Akhlaghi
    Tahereh Faezi
    Zahra Ghodsi
    Alireza Faridar
    Farima Ashofteh
    Bahar Sadeghi Abdollahi
    Clinical Rheumatology, 2010, 29 : 823 - 833
  • [2] Behcet's disease in the Middle East
    Saylan, T
    Mat, C
    Fresko, I
    Melikoglu, M
    CLINICS IN DERMATOLOGY, 1999, 17 (02) : 209 - 223
  • [3] Current Drug Managements of Wilson's Disease: From West to East
    Li, Wen-Jie
    Chen, Chen
    You, Zhi-Fei
    Yang, Ren-Min
    Wang, Xiao-Ping
    CURRENT NEUROPHARMACOLOGY, 2016, 14 (04) : 322 - 325
  • [4] Behcet's Disease (Adamantiades-Behcet's Disease)
    Kaneko, Fumio
    Togashi, Ari
    Saito, Sanae
    Sakuma, Hideo
    Oyama, Noritaka
    Nakamura, Koichiro
    Yokota, Kenji
    Oguma, Keiji
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,
  • [5] Pediatric Behcet's disease; report of 204 cases from the Iran registry of Behcet's disease
    Shahram, F.
    Nadji, A.
    Akhlaghi, M.
    Faezi, S. T.
    Chams-Davatchi, C.
    Shams, H.
    Ghodsi, S. Z.
    Davatchi, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S155 - S155
  • [7] Behcet's disease in patients of west African and Afro-Caribbean origin
    Poon, W
    Verity, DH
    Larkin, GL
    Graham, EM
    Stanford, MR
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (07) : 876 - 878
  • [8] Behcet's disease
    Al-Mutawa, SA
    Hegab, SM
    CLINICAL AND EXPERIMENTAL MEDICINE, 2004, 4 (03) : 103 - 131
  • [9] Behcet's disease
    Saadoun, D.
    REVUE DE MEDECINE INTERNE, 2023, 44 : A299 - A301
  • [10] Behcet's disease
    Kotter, I
    Durk, H
    Saal, JG
    Eckstein, A
    Zierhut, M
    Fierlbeck, G
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 121 (12) : 382 - 388